Insightec Ltd. announced that the Exablate Prostate system received CE Mark for treating locally-confined prostate cancer with MR-guided Focused Ultrasound (MRgFUS).


If you're thinking about taking up running as your New Year's resolution and still need some convincing, consider this: MRI scans reveal that endurance runners' brains have greater functional connectivity than the brains of more sedentary individuals.


Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and therapeutics, announced that the National Cancer Institute exercised the $2M Phase II option of a Small Business Innovation Research (SBIR) Phase I/II fast-track $2.3M contract to develop a new agent to treat metastatic prostate cancer. The contract develops a promising unique radiotherapeutic drug, CTT1403, that targets Prostate-Specific Membrane Antigen (PSMA). 

Colegio Brasileiro de Radiologia (CBR)

European Society of Neuroradiology (ESNR)

Association of Educators in Imaging and Radiological Sciences (AEIRS)

Jornada Paulista de Radiologia (JPR)

American Roentgen Ray Society (ARRS)

Canadian Association of Medical Radiation Technologists (CAMRT) — Ontario Association of Medical Radiation Sciences (OAMRS)

International Society for Magnetic Resonance in Medicine (ISMRM)

Subscribe Now